Subject
Drug Discovery,Pharmacology
Reference96 articles.
1. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment;Leung;Lancet,2020
2. WHO. Coronavirus disease (COVID-19) pandemic. Geneva; WHO, 2020.
3. Regenerative medicine regulatory policies: a systematic review and international comparison;Qiu;Health Policy,2020
4. From clinical proof-of-concept to commercialization of CAR T cells;Calmels;Drug Discov Today,2018
5. FDA. Rare disease therapy development and access remain top FDA priorities during COVID-19. www.fda.gov/news-events/fda-voices/rare-disease-therapy-development-and-access-remain-top-fda-priorities-during-covid-19. Published June 11, 2020. Accessed April 13, 2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献